Us Bancorp \De\ Revance Therapeutics, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,945 shares of RVNC stock, worth $4,998. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,945

Previous 1,770 9.89%

Holding current value

$4,998

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$2.57 - $2.57 $449 - $449	175 Added 9.89%	1,945 $4,000
Q2 2024 Aug 06, 2024	SELL	$2.34 - $4.73 $2,882 - $5,827	-1,232 Reduced 41.04%	1,770 $4,000
Q1 2024 May 07, 2024	BUY	$4.65 - $9.31 $2,664 - $5,334	573 Added 23.59%	3,002 $14,000
Q4 2023 Feb 09, 2024	SELL	$5.81 - $11.2 $4,915 - $9,475	-846 Reduced 25.83%	2,429 $21,000
Q3 2023 Nov 03, 2023	BUY	$11.47 - $25.07 $688 - $1,504	60 Added 1.87%	3,275 $37,000
Q2 2023 Aug 09, 2023	SELL	$24.7 - $37.61 $18,846 - $28,696	-763 Reduced 19.18%	3,215 $81,000
Q1 2023 May 09, 2023	SELL	$18.36 - $35.27 $411,319 - $790,153	-22,403 Reduced 84.92%	3,978 $128,000
Q4 2022 Feb 13, 2023	BUY	$18.32 - $30.66 $171,878 - $287,652	9,382 Added 55.19%	26,381 $486,000
Q3 2022 Oct 27, 2022	BUY	$14.33 - $28.47 $231,386 - $459,705	16,147 Added 1895.19%	16,999 $458,000
Q2 2022 Aug 01, 2022	SELL	$11.52 - $20.4 $14,446 - $25,581	-1,254 Reduced 59.54%	852 $12,000
Q1 2022 May 11, 2022	SELL	$12.36 - $20.31 $5,253 - $8,631	-425 Reduced 16.79%	2,106 $41,000
Q4 2021 Feb 11, 2022	BUY	$12.46 - $27.87 $28,109 - $62,874	2,256 Added 820.36%	2,531 $41,000
Q1 2021 Apr 28, 2021	BUY	$24.03 - $29.97 $432 - $539	18 Added 7.0%	275 $8,000
Q2 2020 Aug 07, 2020	BUY	$12.6 - $26.55 $743 - $1,566	59 Added 29.8%	257 $6,000
Q4 2019 Feb 04, 2020	SELL	$11.66 - $20.15 $6,354 - $10,981	-545 Reduced 73.35%	198 $3,000
Q3 2019 Nov 08, 2019	BUY	$10.22 - $14.5 $2,023 - $2,871	198 Added 36.33%	743 $10,000
Q2 2019 Aug 13, 2019	SELL	$10.67 - $15.49 $1,365 - $1,982	-128 Reduced 19.02%	545 $7,000
Q1 2019 May 08, 2019	BUY	$15.4 - $20.39 $2,664 - $3,527	173 Added 34.6%	673 $11,000
Q4 2018 Feb 13, 2019	SELL	$18.06 - $24.96 $4,695 - $6,489	-260 Reduced 34.21%	500 $10,000
Q2 2018 Aug 08, 2018	BUY	$27.45 - $33.35 $7,137 - $8,671	260 Added 52.0%	760 $21,000
Q1 2018 May 08, 2018	BUY	$29.15 - $37.4 $14,575 - $18,700	500 New	500 $15,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account